CYTK:NASDAQ
Cytokinetics, Inc.
$73.77
arrow_upward
+0.20%(+0.15) 1D
$73.77
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 11, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CYTK...
Open
$74.66
High
$75.98
Low
$73.50
Mkt. cap
10.26B
Avg. vol.
1.88M
Volume
1.72M
52-wk high
$88.31
52-wk low
$47.22
EPS
-$7.22
Beta
0.36
Shares outstanding
139.02M
No. of employees
673
Open
$74.66
High
$75.98
Low
$73.50
Mkt. cap
10.26B
Avg. vol.
1.88M
Volume
1.72M
52-wk high
$88.31
52-wk low
$47.22
EPS
-$7.22
Beta
0.36
Shares outstanding
139.02M
No. of employees
673
News stories
From web sources and news partners
GuruFocus
·
2 hours ago
Cytokinetics Inc (CYTK) Director Robert Landry Sells 1,000 Shares
Investing.com
·
4 hours ago
Cytokinetics director Robert Landry sells $74,660 in shares
Stock Titan
·
8 hours ago
Cytokinetics (NASDAQ: CYTK) director plans 2,000-share Rule 144 sale
Profile
Cytokinetics, Incorporated, is a biopharmaceutical company based in South San Francisco, California, that develops muscle activators and muscle inhibitors as potential treatments for people with diseases characterized by impaired or declining muscle function. Wikipedia
About Cytokinetics, Inc.
CEORobert I. Blum | Robert I. Blum
Employees673
Founded1997
HeadquartersSouth San Francisco, California, United States
SectorBiotechnology
Websitecytokinetics.com